196 related articles for article (PubMed ID: 11485532)
1. Serum levels of transforming growth factor beta1 in patients with breast cancer.
Sheen-Chen SM; Chen HS; Sheen CW; Eng HL; Chen WJ
Arch Surg; 2001 Aug; 136(8):937-40. PubMed ID: 11485532
[TBL] [Abstract][Full Text] [Related]
2. Serum levels of hepatocyte growth factor in patients with breast cancer.
Sheen-Chen SM; Liu YW; Eng HL; Chou FF
Cancer Epidemiol Biomarkers Prev; 2005 Mar; 14(3):715-7. PubMed ID: 15767355
[TBL] [Abstract][Full Text] [Related]
3. Transforming growth factor beta 1 serum levels in patients with preinvasive and invasive lesions of the breast.
Lebrecht A; Grimm C; Euller G; Ludwig E; Ulbrich E; Lantzsch T; Hefler L; Koelbl H
Int J Biol Markers; 2004; 19(3):236-9. PubMed ID: 15503826
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of predictive and prognostic significance of serum TGF-beta1 levels in breast cancer according to HER-2 codon 655 polymorphism.
Papadopoulou E; Anagnostopoulos K; Tripsianis G; Tentes I; Kakolyris S; Galazios G; Sivridis E; Simopoulos K; Kortsaris A
Neoplasma; 2008; 55(3):229-38. PubMed ID: 18348656
[TBL] [Abstract][Full Text] [Related]
5. Serum concentration of tumor necrosis factor in patients with breast cancer.
Sheen-Chen SM; Chen WJ; Eng HL; Chou FF
Breast Cancer Res Treat; 1997 May; 43(3):211-5. PubMed ID: 9150900
[TBL] [Abstract][Full Text] [Related]
6. Serum levels of matrix metalloproteinase 2 in patients with breast cancer.
Sheen-Chen SM; Chen HS; Eng HL; Sheen CC; Chen WJ
Cancer Lett; 2001 Nov; 173(1):79-82. PubMed ID: 11578812
[TBL] [Abstract][Full Text] [Related]
7. Circulating soluble Fas in patients with breast cancer.
Sheen-Chen SM; Chen HS; Eng HL; Chen WJ
World J Surg; 2003 Jan; 27(1):10-3. PubMed ID: 12557031
[TBL] [Abstract][Full Text] [Related]
8. Elevated plasma transforming growth factor-beta 1 levels in breast cancer patients decrease after surgical removal of the tumor.
Kong FM; Anscher MS; Murase T; Abbott BD; Iglehart JD; Jirtle RL
Ann Surg; 1995 Aug; 222(2):155-62. PubMed ID: 7543740
[TBL] [Abstract][Full Text] [Related]
9. Elevated serum levels of transforming growth factor-beta1 in patients with colorectal carcinoma: its association with tumor progression and its significant decrease after curative surgical resection.
Shim KS; Kim KH; Han WS; Park EB
Cancer; 1999 Feb; 85(3):554-61. PubMed ID: 10091729
[TBL] [Abstract][Full Text] [Related]
10. Serum levels of soluble E-selectin in women with breast cancer.
Sheen-Chen SM; Eng HL; Huang CC; Chen WJ
Br J Surg; 2004 Dec; 91(12):1578-81. PubMed ID: 15386328
[TBL] [Abstract][Full Text] [Related]
11. Preoperative transforming growth factor-beta 1 (TGF-beta 1) plasma levels in operable breast cancer patients.
Chod J; Zavadova E; Halaska MJ; Strnad P; Fucikova T; Rob L
Eur J Gynaecol Oncol; 2008; 29(6):613-6. PubMed ID: 19115689
[TBL] [Abstract][Full Text] [Related]
12. Prognostic utility of circulating transforming growth factor beta 1 in breast cancer patients.
Dave H; Shah M; Trivedi S; Shukla S
Int J Biol Markers; 2012; 27(1):53-9. PubMed ID: 22020368
[TBL] [Abstract][Full Text] [Related]
13. Preoperative plasma levels of transforming growth factor beta(1) (TGF-beta(1)) strongly predict progression in patients undergoing radical prostatectomy.
Shariat SF; Shalev M; Menesses-Diaz A; Kim IY; Kattan MW; Wheeler TM; Slawin KM
J Clin Oncol; 2001 Jun; 19(11):2856-64. PubMed ID: 11387358
[TBL] [Abstract][Full Text] [Related]
14. Elevated plasma levels of transforming growth factor-beta 1 (TGF-beta 1) in patients with advanced breast cancer: association with disease progression.
Ivanović V; Todorović-Raković N; Demajo M; Nesković-Konstantinović Z; Subota V; Ivanisević-Milovanović O; Nikolić-Vukosavljević D
Eur J Cancer; 2003 Mar; 39(4):454-61. PubMed ID: 12751375
[TBL] [Abstract][Full Text] [Related]
15. Elevated serum levels of transforming growth factor beta1 in Epstein-Barr virus-associated nasopharyngeal carcinoma patients.
Xu J; Menezes J; Prasad U; Ahmad A
Int J Cancer; 1999 Aug; 84(4):396-9. PubMed ID: 10404092
[TBL] [Abstract][Full Text] [Related]
16. Circulating levels of transforming growth factor-βeta (TGF-β) and chemokine (C-X-C motif) ligand-1 (CXCL1) as predictors of distant seeding of circulating tumor cells in patients with metastatic breast cancer.
Divella R; Daniele A; Savino E; Palma F; Bellizzi A; Giotta F; Simone G; Lioce M; Quaranta M; Paradiso A; Mazzocca A
Anticancer Res; 2013 Apr; 33(4):1491-7. PubMed ID: 23564790
[TBL] [Abstract][Full Text] [Related]
17. Plasma TGF-beta1-related survival of postmenopausal metastatic breast cancer patients.
Nikolić-Vukosavljević D; Todorović-Raković N; Demajo M; Ivanović V; Nesković B; Markićević M; Nesković-Konstantinović Z
Clin Exp Metastasis; 2004; 21(7):581-5. PubMed ID: 15787095
[TBL] [Abstract][Full Text] [Related]
18. Serum levels of transforming growth factor beta1 are significantly correlated with venous invasion in patients with gastric cancer.
Lin Y; Kikuchi S; Obata Y; Yagyu K;
J Gastroenterol Hepatol; 2006 Feb; 21(2):432-7. PubMed ID: 16509870
[TBL] [Abstract][Full Text] [Related]
19. Serum Transforming Growth Factor-β1 Change After Neoadjuvant Chemoradiation Therapy Is Associated With Postoperative Pulmonary Complications in Esophageal Cancer Patients Undergoing Combined Modality Therapy.
Lu SL; Hsu FM; Tsai CL; Wu JK; Lee JM; Huang PM; Hsu CH; Koong AC; Chang DT; Cheng JC
Int J Radiat Oncol Biol Phys; 2015 Dec; 93(5):1023-31. PubMed ID: 26475065
[TBL] [Abstract][Full Text] [Related]
20. Screening of circulating TGF-β levels and its clinicopathological significance in human breast cancer.
Panis C; Herrera AC; Victorino VJ; Aranome AM; Cecchini R
Anticancer Res; 2013 Feb; 33(2):737-42. PubMed ID: 23393376
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
